Actinium Pharmaceuticals, Inc. (ATNM)
R&D Expenses
$18.74M
TTM · Period ending: · USD
ATNM R&D Expenses
Latest reported$18.74Mperiod ending
Latest reported$18.74Mperiod ending
ATNM R&D Expenses ($0.00 → $18.74M)
Annual R&D Expenses
High-resolution chart · PNG
ATNM r&d expenses history
Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | R&D Expenses (USD) |
|---|---|
| 21,124,000 | |
| 30,045,000 | |
| 38,670,000 | |
| 23,135,000 | |
| 17,507,000 | |
| 16,085,000 | |
| 16,549,693 | |
| 17,095,000 | |
| 17,700,000 | |
| 17,501,000 | |
| 13,312,000 | |
| 12,267,000 | |
| 2,667,000 | |
| 3,440,000 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 | |
| 0 |